ETBX-071
Showing 1 - 22 of 22
Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,
Completed
- Prostatic Neoplasms
- Prostatic Cancer
- ETBX-071; adenoviral PSA vaccine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 28, 2021
Colorectal Cancer Metastatic, mCRC Trial in El Segundo (biological, drug, procedure)
Active, not recruiting
- Colorectal Cancer Metastatic
- mCRC
- Aldoxorubicin Hydrochloride
- +19 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Parkinson Disease, Healthy Participants Trial in United States (TAK-071, Placebo)
Active, not recruiting
- Parkinson Disease
- Healthy Participants
- TAK-071
- Placebo
-
Garden Grove, California
- +20 more
Nov 30, 2022
Rheumatoid Arthritis (RA) Trial in Worldwide (NI-071, Infliximab)
Completed
- Rheumatoid Arthritis
-
Little Rock, Arkansas
- +133 more
Jan 26, 2023
Papillomavirus Infections Trial in Quzhou, Taizhou (9vHPV vaccine)
Active, not recruiting
- Papillomavirus Infections
- 9vHPV vaccine
-
Quzhou, Zhejiang, China
- +1 more
Sep 1, 2022
Tumors, Prostate Cancer, Lung Cancer Trial run by the NCI (ETBX-051; adenoviral brachyury vaccine, ETBX-061; adenoviral Mucin-1
Completed
- Neoplasms
- +4 more
- ETBX-051; adenoviral brachyury vaccine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 25, 2020
Stroke Hemorrhagic Trial in Dallas (fMRI)
Completed
- Stroke Hemorrhagic
- fMRI
-
Dallas, TexasUT Southwestern Medical Center
Jul 30, 2021
Cancer Trial in El Segundo, Sioux Falls (ETBX-021)
Unknown status
- Cancer
- ETBX-021
-
El Segundo, California
- +1 more
Aug 23, 2019
Thyroid Cancer, Colon Cancer, Ovarian Cancer Trial in Spokane (ETBX-011, ALT-803)
Completed
- Thyroid Cancer
- +5 more
- ETBX-011
- ALT-803
-
Spokane, WashingtonMedical Oncology Associates
Aug 23, 2019
Healthy Volunteers Trial in Glendale (Scopolamine, TAK-071, Donepezil)
Alzheimer, Healthy Volunteers Trial in Glendale (TAK-071, Donepezil, TAK-071 Placebo)
Terminated
- Alzheimer Disease
- Healthy Volunteers
- TAK-071
- +3 more
-
Glendale, California(unnamed)
Mar 8, 2019
Glycogen Depletion, Insulin Sensitivity Trial in Copenhagen (Glycogen Supercompensation)
Completed
- Glycogen Depletion
- Insulin Sensitivity
- Glycogen Supercompensation
-
Copenhagen, Capital Region, DenmarkDepartment of Nutrition, Exercise and Sports
Mar 1, 2018
Treatment De-Intensification and Residual HIV-1 in Youth
Completed
- HIV-1
- HIV Infections
- Blood draw
-
Los Angeles, California
- +16 more
Feb 27, 2017
Breast Cancer Trial (Pegylated liposomal doxorubicin (SCH 200746), Capecitabine)
Completed
- Breast Cancer
- Pegylated liposomal doxorubicin (SCH 200746)
- Capecitabine
- (no location specified)
May 12, 2017
Neurocognitive Assessment in Youth Initiating HAART
Completed
- HIV Infections
- Early Treatment with HAART
- +2 more
-
Los Angeles, California
- +20 more
Feb 27, 2017
HIV Trial (Comparator: Raltegravir 400 mg b.i.d., Experimental: Raltegravir 800 mg q.d., TRUVADA™)
Terminated
- HIV
- Comparator: Raltegravir 400 mg b.i.d.
- +2 more
- (no location specified)
Feb 14, 2017
Rheumatoid Arthritis Trial in Sendai-Shi (NI-071, Infliximab)
Completed
- Rheumatoid Arthritis
- NI-071
- Infliximab
-
Sendai-Shi, JapanNichiIko Investigational Site
Apr 6, 2016
Healthy Trial in Tokyo (NI-071, Infliximab)
Completed
- Healthy
- NI-071
- Infliximab
-
Tokyo, JapanNichiIko Investigational Site
Jun 27, 2014
Rheumatoid Arthritis Trial in Sendai (Infliximab)
Completed
- Rheumatoid Arthritis
- Infliximab
-
Sendai, Miyagi, Japan392001001
Jun 18, 2013
Colon Cancer, Lung Cancer, Breast Cancer Trial in Durham, Spokane (AD5 CEA Vaccine)
Completed
- Colon Cancer
- +2 more
- AD5 CEA Vaccine
-
Durham, North Carolina
- +1 more
Mar 21, 2013